168 related articles for article (PubMed ID: 24571671)
1. Treatment of the acute sickle cell vaso-occlusive crisis in the Emergency Department: a Brazilian method of switching from intravenous to oral morphine.
Campos J; Lobo C; Queiroz AM; do Nascimento EM; Lima CB; Cardoso G; Ballas SK
Eur J Haematol; 2014 Jul; 93(1):34-40. PubMed ID: 24571671
[TBL] [Abstract][Full Text] [Related]
2. Systemic exposure to morphine and the risk of acute chest syndrome in sickle cell disease.
Kopecky EA; Jacobson S; Joshi P; Koren G
Clin Pharmacol Ther; 2004 Mar; 75(3):140-6. PubMed ID: 15001964
[TBL] [Abstract][Full Text] [Related]
3. Oral morphine protocol for sickle cell crisis pain.
Conti C; Tso E; Browne B
Md Med J; 1996 Jan; 45(1):33-5. PubMed ID: 8569458
[TBL] [Abstract][Full Text] [Related]
4. Patient-controlled analgesia versus continuous infusion of morphine during vaso-occlusive crisis in sickle cell disease, a randomized controlled trial.
van Beers EJ; van Tuijn CF; Nieuwkerk PT; Friederich PW; Vranken JH; Biemond BJ
Am J Hematol; 2007 Nov; 82(11):955-60. PubMed ID: 17617790
[TBL] [Abstract][Full Text] [Related]
5. Effect of ketorolac in pediatric sickle cell vaso-occlusive pain crisis.
Hardwick WE; Givens TG; Monroe KW; King WD; Lawley D
Pediatr Emerg Care; 1999 Jun; 15(3):179-82. PubMed ID: 10389953
[TBL] [Abstract][Full Text] [Related]
6. Is morphine exposure associated with acute chest syndrome in children with vaso-occlusive crisis of sickle cell disease? A 6-year case-crossover study.
Finkelstein Y; Schechter T; Garcia-Bournissen F; Kirby M; Nurmohamed L; Juurlink DN; Blanchette V; Koren G
Clin Ther; 2007 Dec; 29(12):2738-43. PubMed ID: 18201591
[TBL] [Abstract][Full Text] [Related]
7. Opioid selection during sickle cell pain crisis and its impact on the development of acute chest syndrome.
Buchanan ID; Woodward M; Reed GW
Pediatr Blood Cancer; 2005 Oct; 45(5):716-24. PubMed ID: 15926170
[TBL] [Abstract][Full Text] [Related]
8. Randomised trial of oral morphine for painful episodes of sickle-cell disease in children.
Jacobson SJ; Kopecky EA; Joshi P; Babul N
Lancet; 1997 Nov; 350(9088):1358-61. PubMed ID: 9365450
[TBL] [Abstract][Full Text] [Related]
9. IF IM in a crisis: Intranasal fentanyl versus intravenous morphine in adult vaso-occlusive crisis.
Assad O; Zamora R; Brown K; Melnitsky L; Moses J; Sherman V
Am J Emerg Med; 2023 Feb; 64():86-89. PubMed ID: 36481614
[TBL] [Abstract][Full Text] [Related]
10. Intermittent injection vs patient-controlled analgesia for sickle cell crisis pain. Comparison in patients in the emergency department.
Gonzalez ER; Bahal N; Hansen LA; Ware D; Bull DS; Ornato JP; Lehman ME
Arch Intern Med; 1991 Jul; 151(7):1373-8. PubMed ID: 2064488
[TBL] [Abstract][Full Text] [Related]
11. Timing of opioid administration as a quality indicator for pain crises in sickle cell disease.
Mathias MD; McCavit TL
Pediatrics; 2015 Mar; 135(3):475-82. PubMed ID: 25667245
[TBL] [Abstract][Full Text] [Related]
12. High-dose intravenous methylprednisolone therapy for pain in children and adolescents with sickle cell disease.
Griffin TC; McIntire D; Buchanan GR
N Engl J Med; 1994 Mar; 330(11):733-7. PubMed ID: 8107739
[TBL] [Abstract][Full Text] [Related]
13. Primary hyperparathyroidism mimicking vaso-occlusive crises in sickle cell disease.
Krishnamoorthy P; Alyaarubi S; Abish S; Gale M; Albuquerque P; Jabado N
Pediatrics; 2006 Aug; 118(2):e537-9. PubMed ID: 16882790
[TBL] [Abstract][Full Text] [Related]
14. [Pain crises in patients with sickle cell diseases. Pathogenesis, clinical aspects, therapy].
Dickerhoff R; von Ruecker A
Klin Padiatr; 1995; 207(6):321-5. PubMed ID: 8569133
[TBL] [Abstract][Full Text] [Related]
15. Use of a clinical pathway to improve the acute management of vaso-occlusive crisis pain in pediatric sickle cell disease.
Ender KL; Krajewski JA; Babineau J; Tresgallo M; Schechter W; Saroyan JM; Kharbanda A
Pediatr Blood Cancer; 2014 Apr; 61(4):693-6. PubMed ID: 24249617
[TBL] [Abstract][Full Text] [Related]
16. Adult emergency department patients with sickle cell pain crisis: a learning collaborative model to improve analgesic management.
Tanabe P; Artz N; Mark Courtney D; Martinovich Z; Weiss KB; Zvirbulis E; Hafner JW
Acad Emerg Med; 2010 Apr; 17(4):399-407. PubMed ID: 20370779
[TBL] [Abstract][Full Text] [Related]
17. Hyperbaric oxygen therapy for vaso-occlusive crises in nine patients with sickle-cell disease.
Stirnemann J; Letellier E; Aras N; Borne M; Brinquin L; Fain O
Diving Hyperb Med; 2012 Jun; 42(2):82-4. PubMed ID: 22828815
[TBL] [Abstract][Full Text] [Related]
18. Oral versus intravenous opioid dosing for the initial treatment of acute musculoskeletal pain in the emergency department.
Miner JR; Moore J; Gray RO; Skinner L; Biros MH
Acad Emerg Med; 2008 Dec; 15(12):1234-40. PubMed ID: 18945240
[TBL] [Abstract][Full Text] [Related]
19. A Multinational Trial of Prasugrel for Sickle Cell Vaso-Occlusive Events.
Heeney MM; Hoppe CC; Abboud MR; Inusa B; Kanter J; Ogutu B; Brown PB; Heath LE; Jakubowski JA; Zhou C; Zamoryakhin D; Agbenyega T; Colombatti R; Hassab HM; Nduba VN; Oyieko JN; Robitaille N; Segbefia CI; Rees DC;
N Engl J Med; 2016 Feb; 374(7):625-35. PubMed ID: 26644172
[TBL] [Abstract][Full Text] [Related]
20. Safety of an ED High-Dose Opioid Protocol for Sickle Cell Disease Pain.
Tanabe P; Martinovich Z; Buckley B; Schmelzer A; Paice JA
J Emerg Nurs; 2015 May; 41(3):227-35. PubMed ID: 25241635
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
